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Abstract
The ubiquitin-proteasome system (UPS) plays a crucial part in normal cell function by medi-
ating intracellular protein clearance. We have previously shown that UPS-mediated protein
degradation varies in a cell type-specific manner in C. elegans. Here, we use formalin-fixed,
paraffin-embedded C. elegans sections to enable studies on endogenous proteasome tis-
sue expression. We show that the proteasome immunoreactivity pattern differs between cell
types and within subcellular compartments in adult wild-type (N2) C. elegans. Interestingly,
widespread knockdown of proteasome subunits by RNAi results in tissue-specific changes
in proteasome expression instead of a uniform response. In addition, long-lived daf-2
(e1370) mutants with impaired insulin/IGF-1 signaling (IIS) display similar proteasome tis-
sue expression as aged-matched wild-type animals. Our study emphasizes the importance
of alternate approaches to the commonly used whole animal lysate-based methods to
detect changes in proteasome expression occurring at the sub-cellular, cell or tissue resolu-
tion level in a multicellular organism.
Introduction
Correct maintenance of the lifecycle of proteins, i.e., from their synthesis to their degradation,
is critical for all organisms. In eukaryotic cells, intracellular protein turnover is mediated by
two evolutionarily conserved systems: the autophagy-lysosome pathway and the ubiquitin-
proteasome system (UPS). In the UPS, polyubiquitin-marked proteins are routed to a large
protease complex, the 26S proteasome, for their proteolytic degradation [1]. The 26S protea-
some is a multi-subunit protease complex consisting of a proteolytic core particle known as
the 20S proteasome capped by one or two 19S regulatory particles [2]. Alternatively, the 20S
can associate with the 11S complexes or PA200/Blm10 (proteasome activator 200 kDa/bleomy-
cin resistance protein-10) [3]. The 20S proteasome is composed of four stacked heterohepta-
meric rings: two α- and two β-rings, each containing seven α- or β-subunits. The proteolytic
activity of the proteasome is conveyed by the β-rings [4]. Proteasome genes are highly con-
served and the Caenorhabditis elegans (C. elegans) orthologues of human 20S proteasome sub-
units are referred to as proteasome alpha subunits 1 to 7 (pas-1-7) and proteasome beta
subunits 1 to 7 (pbs-1-7) [5].
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Regulation of proteasome function is complex, affecting its abundance, composition and
proteolytic processing capacity. Proteasome activity can be directly regulated through post-
translational modifications of the proteasome, such as phosphorylation by protein kinase A
[6]. The capacity for proteasome’s substrate degradation can also be affected by associated ubi-
quitin ligases (E3s) and deubiquitinating enzymes (DUBs) [7, 8]. Proteasome abundance is at
least partly regulated through a negative feedback loop, also known as the “bounce-back”
effect, by which transcription of proteasome subunits is promoted upon impaired cellular pro-
teasome activity [9, 10]. In yeast, this effect is regulated by the transcription factor Rpn4p,
which is also a proteasome subunit. In mammalian cells and in C. elegans, the Rpn4p-unrelated
transcription factors Nrf1/2 and SKN-1 mediate this bounce-back effect, respectively [10–14].
Other transcription factors affecting proteasome abundance are FOXO (forkhead box O) tran-
scription factors DAF-16 in C. elegans and FOXO4 in mammals by influencing transcription
of the 19S regulatory particle subunit Rpn6 [15, 16]. However, regulation of basal proteasome
gene expression is for the moment fairly unknown.
We have previously developed fluorescent-based reporters for in vivo measurement of UPS
activity in live C. elegans and shown that UPS-mediated protein degradation varies in a cell-
type and age-dependent manner [7, 17]. We have also demonstrated that long-lived daf-2
(e1370)mutants with reduced insulin/IGF-1 (insulin-like growth factor) signaling (IIS) display
increased in vivo UPS activity in body-wall muscle cells and intestinal cells, without any detect-
able difference in proteasome amount in whole animal lysates [7]. Although Western blotting
and mass spectrometry-based quantitative proteomics on whole animal homogenates are cur-
rently the most commonly used methods to study protein abundance in C. elegans, these meth-
ods exclude tissue and cell-type specific protein expression analysis. To address this issue, we
have performed immunohistochemistry on formalin-fixed, paraffin-embedded C. elegans to
semi-quantitatively study proteasome expression at a tissue- and cell-level resolution. To date,
immunohistochemistry in C. elegans has only been reported in a few studies on localization
and accumulation of the aggregation-prone human tau and amyloid-beta proteins [18, 19].
Here, we utilize immunohistochemistry to detect expression of endogenous proteins in C.
elegans.
Our study reveals that wild-type C. elegans displays variable proteasome immunoreactivity
within different cell types and subcellular compartments. We also show that proteasome
expression is affected in a tissue-specific manner upon widespread targeted 20S α-subunit
knockdown. Furthermore, we demonstrate that impaired insulin/IGF-1 signaling of daf-2
(e1370)mutants does not affect tissue expression of the proteasome, when compared to wild-
type animals, supporting a role for tissue-specific post-translational regulation of UPS activity.
Materials and methods
Nematodes and growth conditions
C. elegans strains were grown under standard conditions at 20˚C as previously described [20].
The following strains were obtained and used from the Caenorhabditis Genetics Center
(CGC): N2 [wild-type Bristol isolate], and CB1370: daf-2(e1370)III. GR1702: Is[sur-5::GFP]
strain was a kind gift from Dr. Gary Ruvkun and previously described [21].
Gel electrophoresis followed by immunoblot analysis or in-gel
proteasome activity assay
Age-synchronized N2 animals at day 1 of adulthood (4 days old) were collected in M9 buffer
(22 mM KH2PO4, 41 mM Na2HPO4, 8,5 mM NaCl, and 19 mM NH4Cl) prior to freezing in
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-80˚C. Animals were homogenized using a dounce homogenizer and native gel lysis buffer, as
previously described [7]. Western blot samples were separated on a SDS- (sodium dodecyl sul-
fate) polyacrylamide gel and blotted onto a nitrocellulose membrane using Trans-Blot Turbo
Transfer System (Bio-Rad). Proteasome 20S α-subunits antibody (MCP231, Enzo Life Sci-
ences) in 1:1000 dilution and anti-α-tubulin antibody (T5168, Sigma) in 1:10000 dilution were
used in blotting. The anti-20S antibody recognizes six out of the seven α-subunits of the 20S
proteasome (α1, α2, α3, α5, α6 and α7). Due to similar molecular masses of these α-subunits
only four separate bands are usually detected. Signal intensity of the immunoblots was ad-
justed and quantified using image processing software based on ImageJ (Fiji Life-line version,
2015 December 22). Native gel electrophoresis and the in-gel proteasome activity assay were
performed as earlier reported with a few exceptions [7]. Gels were run in an ice bath for 30
minutes at 20 mA and then for 1 hour and 40 minutes at 40 mA. Following gel electrophoresis,
the gel was either blotted onto a nitrocellulose membrane prior to immunoblotting with the
anti-20S α-subunits antibody or incubated in developing buffer containing 160 μM of fluoro-
genic proteasome substrate suc-LLVY-AMC (succinyl-leu-leu-val-tyr-7-amino-4-methylcou-
marin) (l-1395, Bachem). Developed gels were exposed to ultraviolet light and imaged with
MultiImage Light Cabinet using FluorChem 8900 software (Alpha Innotech Corporation). Sig-
nal intensity was adjusted using Fiji Life-line version, 2015 December 22.
Immunohistochemical analysis
Immunohistochemical analyses were performed on age-synchronized animals. Animals at 1
day of adulthood (4-day old N2, and 4-day old sur-5::gfp transgenic animals, and 5-day old
daf-2(e1370)mutants) were washed in M9 buffer and fixed in 10% (v/v) phosphate buffered
formalin for 20 minutes at room temperature. Formalin-fixed animals were then embedded in
agar (2% w/v in Milli-Q), and fixed again in 10% (v/v) phosphate buffered formalin overnight,
prior to processing the agar blocks into paraffin. Paraffin-embedded agar blocks were cut into
4-μm sections, fixed on slides and dried for 12 to 24 hours at 37˚C. Sections were deparaffi-
nized in xylene and rehydraded through gradually decreasing concentrations of ethanol to dis-
tilled water. For antigen retrieval slides were treated in a PreTreatment module (Lab Vision)
in 0,05 M Tris-HCl buffer, pH 8,5 for 20 minutes at 98˚C prior to immunohistochemistry.
Immunohistochemical staining was performed using Dako REALTM EnVisionTM Detection
System, Peroxidase/DAB+, Rabbit/Mouse kit (Dako) as reported earlier [22]. The slides were
incubated for an hour at room temperature with either the proteasome 20S α-subunits anti-
body (MCP231, Enzo Life Sciences) in 1:2000 dilution or anti-GFP antibody (11814460001,
Roche) in 1:5000 dilution. The immunoreaction was developed with a 3,3’-diaminobenzidine
tetrahydrochloride (DAB) chromogen (DAKO) resulting in a brown reaction product. Sam-
ples were counterstained with Mayer’s haematoxylin solution, rinsed in tap water and dehy-
drated through gradually increasing concentrations of ethanol to xylene before being mounted
with Pertex1 mounting medium (HistoLab). Antibody specificity in the section was demon-
strated by pre-incubating the antibody with purified human 20S proteasome (E-360, R&D Sys-
tems) in 1:100 dilution for an hour at room temperature before incubated with the sections.
The slides were imaged either with a Zeiss Axio Imager.Z1 upright epifluorescence microscope
connected to an AxioCam Mrc5, 5 megapixel color CCD camera (Zeiss) and Zen 2 software
(Zeiss) or a Zeiss Axio Imager.Z2 upright epifluorescence microscope connected to an Axio-
Cam 105 color, 5 megapixel color CMOS camera (Zeiss) and Zen 2 pro software (Zeiss).
Images were acquired either with 10x 0.3 NA, 40x 0.75 NA EC Plan Neofluar objectives, or
with a 63x 1.4 NA Plan Apochromat objective. Micrographs were processed with Photoshop
CS6 software (Adobe Systems). Evaluation of immunostaining was done independently by
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two investigators. Staining intensity was scored as 0 for negative, 1 for mild, 2 for moderate,
and 3 for strong positive immunoreactivity.
C. elegans in vivo imaging
Age-synchronized animals at day 1 of adulthood (4-day old animals) were mounted on 3%
agarose pads and immobilized using 0,5 mM levamisole in M9. Animals were imaged with a
Zeiss Axio Imager.Z2 upright epifluorescence microscope connected to an Orca Flash 4.0 LT,
4 megapixel monochrome sCMOS camera (Hamamatsu) and Zen 2 pro software (Zeiss).
Images were acquired with 40x 0.75 NA EC Plan Neofluar objective. Micrographs were pro-
cessed with Photoshop CS6 software (Adobe Systems).
C. elegans RNA-interference (RNAi)
RNAi was performed using the feeding protocol as described earlier [23]. Bacterial strain
HT115 carrying the empty pL4440 expression vector was used as a control. To induce double-
stranded RNA expression in the bacteria, 0,4 mM isopropyl β-D-1-thiogalactopyranoside
(IPTG) (I6758, Sigma) was used, and its concentration was further increased to 0,8 mM before
seeding the plates. To avoid developmental defects of proteasome downregulation, age-syn-
chronized N2 animals were placed on control RNAi feeding plates as L1 larvae (day 1) and
transferred as L3 larvae (day 2) to RNAi feeding plates targeting pas-5 or pas-6 alone (F25H2.9
and CD4.6, respectively, J. Ahringer RNAi library), or targeting both pas-5 and skn-1 (T19E7.2,
Vidal ORFeome-Based RNAi library). Combined RNAi of pas-5 and skn-1 was performed by
mixing in a 1:1 volume ratio (taken into account the optical density) pas-5 and skn-1 RNAi bac-
terial cultures prior seeding. Accordingly, in this experimental setup the RNAi bacteria targeting
pas-5 or skn-1 alone were diluted in a 1:1 volume ratio with pL4440 bacteria. To knockdown
gfp, age-synchronized sur-5::gfp animals were exposed to gfpRNAi (the bacterial clone was a gift
from Dr. Gary Ruvkun) as L1 larvae (day 1). Animals were harvested at day 1 of adulthood (day
4) for analyses.
Statistical analysis
Statistical significances were determined by Student’s t-test (two-tailed, paired).
Results
Proteasome expression varies in different tissues in adult wild-type C.
elegans
To study proteasome tissue expression in adult wild-type (N2) C. elegans, we performed
immunohistochemistry on sections of formalin-fixed, paraffin-embedded animals. To detect
the proteasome, we used an anti-20S antibody, which has previously been shown to recognize
proteasome α-subunits resolved on SDS-PAGE (S1A Fig and [7]). Analysis of whole animal
lysates by immunoblotting under non-denaturing conditions demonstrated that this antibody
recognizes native α-subunits integrated in proteolytically active proteasome complexes (S1B
and S1C Fig). Importantly, no bands corresponding to free α-subunits were detected, even
after longer exposures, demonstrating that the amount of free α-subunits is non-existing or
very low in the lysates (S1B Fig, data not shown). Immunostaining of the proteasome in adult
C. elegans sections showed clear positive immunoreactivity in most tissues and cell types (Fig
1A and 1B). The immunoreactivity was strongly reduced when the primary antibody was
omitted or pre-absorbed with purified human 20S proteasome, validating the specificity of the
proteasome immunostaining in the sections (S1D Fig). We detected proteasome expression in
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most somatic cell types, such as intestinal cells, body-wall muscle cells and in the gonad,
including germ cells, oocytes and embryos, but not in the extracellular cuticle (Fig 1B and 1C).
In all cell types, immunoreactivity was weaker in the cytoplasm compared to the nucleus and/
or perinuclear space (Fig 1C and 1D). This effect was most prominent in intestinal cells (Fig
1C and 1D). To validate suitability of enzymatic peroxidase-based immunohistochemistry for
comparable antigen detection in different tissues and sub-cellular compartments, we used a
Fig 1. Proteasome tissue expression in wild-type (N2) C. elegans sections. (A) Schematic picture of the
body plan and tissues of an adult hermaphrodite C. elegans. (B) Proteasome immunostaining in a longitudinal
whole animal section (4μm) of 1-day old adult C. elegans. Specific cell types, rachis, and extracellular cuticle
are indicated by arrows. Scale bar: 100 μm. (C) Large magnification images of different areas of the same C.
elegans as presented in (B) showing proteasome immunoreactivity in an intestinal cell (upper left panel,
outlined with a black dash line), body-wall muscle cell (upper right panel, indicated by a black arrow), oocytes
(upper right panel, outlined with white dash lines), germ cells (lower left panel, indicated by a white arrow),
rachis (lower left panel, indicated by a white arrowhead), and embryos (lower right panel, outlined with red
dash lines). Black arrowhead points to the nucleus. Scale bars: 10 μm. (D) Quantification of immunoreactivity.
Graph shows the mean staining intensity of three independent experiments (n = number of animals). Error
bars: ± SEM. ***p < 0,001.
https://doi.org/10.1371/journal.pone.0183403.g001
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transgenic strain expression GFP as a fusion protein from the ubiquitous sur-5 promoter and
compared the GFP immunoreactivity in sections to the GFP fluorescence in live animals. Posi-
tive GFP immunoreactivity was detected in the same tissues, cells and sub-cellular compart-
ments as the GFP fluorescence signal and the intensities of the immunoreactivity correlated
with the GFP fluorescence intensities (S2A and S2B Fig). Taken together, our data show that
proteasome immunoreactivity varies in different cell types and within cellular compartments
in 1-day old adult wild-type C. elegans.
Targeted proteasome subunit knockdown leads to tissue-specific
responses in proteasome expression
We have previously shown that knockdown of the proteasome subunits pas-5 or rpn-2 by
RNAi result in dramatic upregulation of the transcriptional reporters of the proteasomal sub-
units pbs-4, rpt-5 and rpn-11, as well as of the RPN-11::GFP translational fusion protein in C.
elegans [14]. This so-called “bounce-back” response, i.e. a compensatory upregulation of pro-
teasome subunit gene expression upon inhibition of the proteasome, was first described in
mammalian cells and is conserved in C. elegans [9, 14]. Accordingly, pas-5 RNAi treatment
increased the total level of proteasome α-subunits compared to the control treatment, when
whole animal lysates were analyzed by Western blotting with the anti-20S antibody (Fig 2A
and 2B). We next wanted to investigate whether the pas-5 knockdown would affect proteasome
20S α-subunit expression in a tissue-specific manner. Interestingly, immunohistochemically
stained sections of C. elegans revealed that widespread pas-5 RNAi enhances proteasome
immunoreactivity in some cell types, such as intestinal and body-wall muscle cells, whilst a
reduction in expression was detected in oocytes, germ cells and in embryos compared to the
control treatment (Fig 2C and 2D). A similar trend in proteasome expression was also detected
upon pas-6 RNAi treatment (S3A and S3B Fig). The pas-5 and pas-6 RNAi mediated induction
was most prominent in the intestine, particularly in the cytoplasm in response to both pas-5
and pas-6 RNAi (Fig 2D and S3B Fig). The pas-5 RNAi mediated enhancement in proteasome
expression was abolished upon simultaneous knockdown of pas-5 and skn-1, showing a SKN-1
dependency in the bounce-back response (Fig 2E and 2F). To test for variation in RNAi tissue
efficiency, we investigated whether downregulation of gfp is reflected in the GFP immunoreac-
tivity in different tissues. The gfpRNAi experiment showed a similar trend of decreased
expression of GFP in both intestinal and body-wall muscle cells, as detected by immunohisto-
chemical and live fluorescence analyses (S4A and S4B Fig). Taken together, our results reveal
that proteasome expression varies in different tissues and cell compartments in response to
widespread RNAi targeting distinct proteasome subunits.
Long-lived daf-2 mutants show similar proteasome tissue expression
levels as aged-matched wild-type animals
It has previously been reported by various groups that there is either no difference, a reduction
or an increase in proteasome protein levels in lysates of long-lived daf-2 animals compared to
lysates of wild-type animals [7, 24–26]. We have demonstrated that daf-2(e1370) animals exhibit
increased in vivo proteasome activity in intestinal and body-wall muscle cells compared to wild-
type animals, but without any detectable difference in proteasome amount in whole animal
lysates analyzed by Western blotting [7].Therefore, there is a need to more accurately examine
proteasome protein expression levels in tissues of daf-2(e1370)mutants. Immunohistochemi-
cally stained sections of 1-day old adult daf-2(e1370)mutants revealed a similar proteasome
immunoreactivity pattern as in aged-matched wild-type animals, showing proteasome expres-
sion in intestinal cells, body-wall muscle cells, and in the gonad, including germ cells, oocytes,
Proteasome tissue expression
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Fig 2. Targeted pas-5 RNAi results in SKN-1–dependent intestinal upregulation of proteasome α-subunits.
(A) Lysates of wild-type animals treated with control or pas-5 RNAi separated on SDS-PAGE prior to immunoblotting
with anti-20S α-subunits antibody (upper panels). Black arrow points to a band expected to correspond to proteasome
α-subunit 5. Lower panels show α-tubulin expression. The samples were run on the same gel. (B) Quantification of the
immunoblots corresponding to the total intensity of the displayed bands. Graph shows mean relative fold change in
levels of 20S α-subunits, when normalized against α-tubulin. Error bars ±SEM of three independent experiments.
*p < 0.05. (C) Images of an adult wild-type animal fed control (left panel) or pas-5 RNAi bacteria (right panel)
presenting proteasome immunoreactivity in intestinal cells (outlined with black dash lines), oocytes (indicated by white
arrows), and body-wall muscle cells (indicated by black arrows). Black arrowhead points to nucleus. Scale bars: 10
µm. (D) Quantification of immunoreactivity. Graph shows the mean staining intensity of three independent experiments
(n = number of animals). Error bars ±SEM. ***p< 0,001, **p < 0,01, *p < 0,05. (E) Images presenting proteasome
Proteasome tissue expression
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and embryos (Figs 3A and 1C). As in wild-type sections, the proteasome immunoreactivity in
adult daf-2(e1370)mutants was stronger in the nucleus and/or perinuclear space, compared to
the cytoplasm (Figs 3A and 1C). No clear tissue- or cell-compartment specific differences were
detected in proteasome immunoreactivity between daf-2(e1370)mutants and wild-type sections
(Fig 3B). Taken together, we show that proteasome expression is similar at the tissue level
between young adult daf-2(e1370) and wild-type animals.
Discussion
We present here the first report on proteasome tissue expression in C. elegans and demonstrate
that the response to a stress condition can result in tissue-specific variations in proteasome
immunoreactivity in the cytoplasm of intestinal cells (outlined with black dash lines) of wild-type animal fed with control
(upper left panel), diluted pas-5 (upper right panel), diluted skn-1 RNAi bacteria (lower left panel) or a culture containing
both pas-5 and skn-1 RNAi bacteria in 1:1 volume ratio (lower right panel). Scale bars: 10 μm. (F) Quantification of
cytoplasmic proteasome immunoreactivity in the intestinal cells. Graph shows the mean staining intensity of three
independent experiments (n = number of animals). Error bars ±SEM, ***p < 0,001, n.s. = non-significant.
https://doi.org/10.1371/journal.pone.0183403.g002
Fig 3. Proteasome tissue expression is similar in long-lived daf-2(e1370) mutants and wild-type
animals. (A) Large magnification images of a long-lived daf-2(e1370) mutant showing proteasome
immunoreactivity in an intestinal cell (left panel, outlined with a black dash line), body-wall muscle cell (left
panel, indicated by a black arrow), germ cells (middle panel, indicated by a white arrow), rachis (middle panel,
indicated by a white arrowhead), oocytes (middle panel, outlined with a white dash line), and embryos (right
panel, outlined with red dash lines). Black arrowhead points to nucleus. Scale bars: 10 μm. (B) Quantification
of immunoreactivity. Graph shows the mean staining intensity of three independent experiments (n = number
of animals). Wild-type staining intensity data are the same as used in Fig 1D. Error bars ± SEM. No clear
differences (10%) were detected in immunoreactivity.
https://doi.org/10.1371/journal.pone.0183403.g003
Proteasome tissue expression
PLOS ONE | https://doi.org/10.1371/journal.pone.0183403 August 17, 2017 8 / 13
levels. Our study demonstrates the need for a complementary approach with preserved tissue
resolution to the commonly used whole animal lysate-based methods for studies on abundance
of proteasome as well as of other proteins in metazoans.
We performed immunohistochemistry on thin C. elegans longitudinal sections with an anti-
body against six out of the seven proteasomal α-subunits, to reflect the endogenous expression
of the 20S proteasome. To our knowledge there is no corresponding antibody recognizing
multiple β-subunits of the 20S proteasome. Detection of the 20S core particle was chosen as a
proxy for proteasome expression, as the in vivo variations in the number and type of regulatory
particles associated with the 20S proteasome [2, 3], may affect data interpretation. As it has
been proposed that “free” α-type subunits may exist in late passage human embryonic fibro-
blasts [27], we tested whether we could detect free α-subunits in worm lysates. Importantly,
the anti-20S α-subunit antibody detected α-subunits only as parts of the 20S and/or 26S pro-
teasome complexes, showing that positive immunoreaction corresponds to endogenous pro-
teasome expression in C. elegans sections. Our analyses of GFP expressing animals confirm
that the intensity and pattern of immunoreactivity represent the detected in vivo GFP fluores-
cence, demonstrating the suitability of immunohistochemistry for detection of protein expres-
sion in C. elegans sections. We reveal that proteasome is expressed in most tissues and cell
types in an adult wild-type C. elegans, which is in agreement with the ubiquitous proteasome
expression reported for female Drosophila melanogaster [28]. As previously shown in mamma-
lian cells [29], we demonstrate that the proteasome is localized both in the cytoplasm and
nucleus in all observed cell-types in C. elegans. Importantly we show that the proteasome
expression pattern varies between cell types, in particularly the ratio between nuclear and cyto-
plasmic staining.
It is well-known that eukaryotic cells try to compensate for proteasome impairment by pro-
ducing more proteasomes. This coordinated up-regulation of proteasome subunits upon
impaired proteasomal activity was first reported in mammalian cells and is dependent on the
transcription factor Nrf1/2 [9, 10, 12, 13]. We have previously demonstrated that this so called
“bounce-back” response also functions in C. elegans and is largely dependent upon the Nrf
orthologue SKN-1 [14]. Specifically, we showed that knockdown of pas-5 by RNAi increases the
in vivo expression of transcriptional and translational reporters of proteasomal genes predomi-
nantly in the intestine, but also in muscle cells [14]. In agreement, we here reveal that targeted
knockdown of proteasome subunit pas-5 increases proteasome expression predominantly in
intestinal cells, but also in body-wall muscle cells. This strong pas-5 RNAi mediated enhance-
ment in proteasome expression in the intestine is dependent on SKN-1, as also reported previ-
ously [14]. Interestingly, we also observed a reduction in immunoreactivity in embryos and
some cells related to reproduction. It is worth noting that pas-5 or pas-6 RNAi experiments
were started at L3 larval stage to facilitate development into adulthood, as genes encoding the
20S core proteasome are essential for C. elegans development and RNAi experiments started at
L1 larval stage induce developmental arrest (data not shown and [30]). Thus, the downregula-
tion of pas-5 or pas-6 does not seem to be rate limiting for assembly of new proteasomes. Taken
together, our data establish for the first time that there are tissue- and cell-type specific varia-
tions in endogenous proteasome expression during the “bounce back” response in C. elegans.
Insulin/IGF-1 signaling (IIS) pathway is a well-characterized evolutionarily conserved path-
way involved in maintaining cellular protein homeostasis and several quantitative proteomic
studies have been performed in long-lived daf-2 IIS mutants. Dong et al. [24] detected no dif-
ferential expression of 20S proteasome subunits between daf-2(e1370)mutants and N2 animals
at day 1 of adulthood, while a study by Stout et al. [25] showed decreased expression of most
proteasome core subunits in daf-2(1370)mutants compared to N2 animals at first day of adult-
hood. A recent quantitative proteomic study revealed an aging-induced accumulation, at time
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points between day 6 and day 22 of adulthood, of most of 20S and 19S subunits in N2 animals
[26]. This accumulation was enhanced in daf-2(e1370)mutants [26]. We have previously shown
by Western blotting that there is no difference in the total amount of proteasome alpha-subunits
in whole animal lysates from young daf-2(e1370) adults and N2 animals [7]. Here, our immuno-
histochemistry data further confirm that there are no differences in proteasome expression at
the tissue level between daf-2(e1370) and wild-type animals at day 1 of adulthood. This identical
proteasome tissue expression is intriguing, taking into account that we have previously shown
that daf-2(e1370)mutants display increased in vivo UPS activity for example in intestinal cells
compared to wild-type animals [7]. This could at least partially be explained by our previous
finding that the proteasome-associated deubiquitinating enzyme UBH-4 regulates proteasome
activity and that ubh-4 expression is negatively regulated in the intestine by the decreased IIS of
the daf-2(e1370)mutants. Our results are in support of recent studies showing that regulation of
protein turnover in daf-2 mutants is a complex process [7, 31–33].
Immunohistochemistry has both advantages and limitations. The intensity of the immuno-
reactivity might be affected by cell-specific features, such as size and morphology. This semi-
quantitative method, however, is suitable for comparing intensity variations in the same cell
type(s) or tissues upon different treatments or in different strains. It is however possible that
small changes in protein expression in the cell may not be within the detection range of this
semi-quantitative antibody-based method. Compared to whole animal immunofluorescence
experiments, immunohistochemistry on C. elegans sections facilitates efficient antibody tissue
accessibility.
Taken together, our results reveal that a stress condition may elicit tissue-specific protea-
some expression responses in C. elegans. Moreover, our data highlight the importance of
implementing a method that captures changes in protein expression occurring at cell or tissue
resolution level in a multicellular organism.
Supporting information
S1 Fig. Testing the specificity of the antibody against proteasome 20S α-subunits. (A)
Lysates of wild-type animals separated on SDS-PAGE prior to immunoblotting with the anti-
proteasome 20S α-subunits antibody (upper panel). Lower panel shows α-tubulin expression.
(B) Lysates of wild-type animals separated under native conditions prior to immunoblotting
with the anti-proteasome 20S α-subunits antibody. RP2-CP and RP-CP correspond to 26S
with two or one 19S regulatory particle, respectively. CP corresponds to 20S core particle. (C)
Lysates of wild-type animals separated on a native gel followed by in-gel proteasome activity
assay with fluorogenic suc-LLVY-AMC substrate. RP2-CP and RP-CP correspond to 26S with
two or one 19S regulatory particle, respectively. CP corresponds to 20S core particle. (D) For-
malin-fixed, paraffin-embedded wild-type adult (4-day old) C. elegans sections showing
immunoreactivity with anti-20S α-antibody (left panel), with omitted primary antibody (mid-
dle panel), and after pre-absorption with purified human 20S proteasome (right panel). Scale
bars: 100 μm.
(TIF)
S2 Fig. Validating suitability of enzymatic, peroxidase-based immunohistochemistry for
inter-tissue and sub-cellular protein expression comparison. (A) Image presenting GFP
immunoreactivity in a formalin-fixed, paraffin-embedded sections of an adult animal express-
ing GFP as a fusion protein under the control of the ubiquitous sur-5 promoter. Intestinal cells
are outlined with white dash lines and a body-wall muscle cell is indicated by a white arrow.
Scale bar: 50 μm. Inserted an enlarged image of the indicated area with arrowheads pointing to
nuclei of intestinal and muscle cells. (B) Representative GFP fluorescence micrograph (left
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panel) and an overlay with the bright-field micrograph (right panel). Nuclei of body-wall mus-
cle cells and intestinal cells are indicated with a white arrow and with an arrowhead, respec-
tively. Scale bars: 50 μm. Inserted an enlarged image of the indicated area.
(TIF)
S3 Fig. Knockdown of pas-6 similarly affects proteasome expression in the intestine as pas-
5 RNAi. (A) Images of an adult wild-type animal fed with control (left panel) or pas-6 RNAi
bacteria (right panel) presenting proteasome immunoreactivity in intestinal cells (outlined
with black dash lines). Black arrowhead points to nucleus Scale bars: 10 μm. (B) Quantification
of immunoreactivity. Graph shows the mean staining intensity of two independent experi-
ments (n = number of animals). Error bars ± SEM. p< 0,001.
(TIF)
S4 Fig. Testing of RNAi efficiency. (A) Images presenting GFP immunoreactivity in a control
(left panel) or gfpRNAi (right panel) treated GFP-expressing animals. Intestinal cells are out-
lined with white dash lines and body-wall muscle cells are indicated by white arrows. White
arrowhead points to nucleus. Scale bars: 10 μm. (B) Representative GFP fluorescence micro-
graphs of animals treated with control RNAi (upper left panel) or gfpRNAi (upper right
panel). Lower panels show overlay of bright-field micrograph and fluorescence micrograph.
Body-wall muscle cells are indicated with white arrows and intestinal cells with white arrow-
heads. Scale bars: 10 μm. Please note that the GFP fluorescence in the intestine is overexposed
to enable visualization of body-wall muscle cell GFP expression in the same image.
(TIF)
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